v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flow from operating activities:    
Net income (loss) $ 1,580 $ (44,278)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operations:    
Depreciation and amortization 3,136 3,668
Non cash lease expense 36 61
Provision for inventory obsolescence (37)
Gain on SLS Settlement (6,730)
Loss on Helena Settlement 2,500
Provision for credit losses 299 (53)
Change in fair value of warrant liabilities (978) 1,034
Issuance of warrants due to Strategic Advisory Agreement 305
Loss on issuance of common stock to Yorkville in connection with the Side Letter 382
Loss on issuance of common stock in connection with settlements 373 72
Issuance of warrants for services 317
Share-based compensation expense 2,087 5,085
Issuance of common stock as compensation expense for consulting services 108
Director fees paid with RSU’s 128
Loss on extinguishment of debt 5,736
Change in fair value of debt 341 1,087
Non cash interest expense 340 3,782
Changes in operating assets and liabilities:    
Accounts receivable (327) 2,458
Inventory, including current portion 874 6,214
Prepaid expenses and other assets 467 47
Accounts payable (5,615) 1,104
Accrued expenses and other liabilities (3,779) 8,935
Lease liabilities 156 169
Deferred revenue 5,146 117
Net cash provided by (used in) operating activities 339 (3,992)
Issuance of common stock to Dragasac as consideration for inducement agreement 2,460
Repayments of short-term debt - unaffiliated (7,042)
Payment of SEPA commitment fee (300)
Proceeds from merchant cash receivable 891
Redemption of preferred stock (300)
Repayment of merchant cash advance (221)
Repayments of short-term debt - related parties (77)
Proceeds from June 2026 Promissory Note 1,000
Proceeds from Gordon Promissory Note 325
Tax withholding on vesting of restricted stock units (112)
Proceeds from the sale of common stock in PIPE Offering 1,010
Net cash (used in) provided by financing activities (6,317) 3,951
Net decrease in cash, cash equivalents and restricted cash (5,978) (41)
Cash, cash equivalents and restricted cash at beginning of period 16,372 10,977
Cash, cash equivalents and restricted cash at end of period 10,394 10,936
Supplemental disclosure of cash flow information:    
Cash paid for income taxes
Supplemental non-cash investing and financing activities:    
NexGel convertible promissory note issued to settle liabilities with Helena and Sequence 5,000
Conversion of Series A Preferred Stock to Promissory Note 1,942
Change in fair value of contingent consideration 650
Issuance of common stock in connection with note payable conversion 922
Reclassification of warrants from liability classified to equity classified 501
Deemed dividend relating to inducement of Dragasac warrants $ 64